Recommendations from the European Commission Initiative on Breast Cancer on multigene tests to guide the use of adjuvant chemotherapy in patients who have hormone receptor positive, HER-2 negative, lymph node negative or up to 3 lymph nodes positive invasive breast cancer

for the Guidelines Development Group European Commission Initiative on Breast Cancer

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)S12-S13
JournalEuropean Journal of Cancer
Volume138
DOIs
Publication statusPublished - Oct 2020

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this